What ever happened to Menu Foods?

Menu Foods was a company that ran into a huge amount of trouble for distributing pet food that contained Melamine, which caused kidney problems in pets, sometimes leading to death. The first precautionary recall was in March 2007 and then it took another month for them to isolate what exactly was causing the problem. It was through a supplier, ChemNutra Inc., who used wheat gluten that was imported from Xuzhou Anying Biologic Technology Development Co. in Wangdien, China. The whole history of the case is documented on the company’s website here.

These series of events took the company’s units from seven dollars a share to about one dollar less than a year after the news broke. Financially, the company is not on solid ground – although it was somewhat profitable before this incident (making about $24 million in distributable cash in calendar 2006), its balance sheet was quite leveraged, with a net debt of about $100 million.

Fast forward a few years, it still has the debt – some $105 million. The only difference is that $75 million matures in October 2010. The company breached its covenants in 2007 (primarily due to the aforementioned recall) and as a result had to cut its distributions to zero and pay its creditors a rate of LIBOR plus 5.8%.

Lately, however, the company seems to have recovered from its near-death experience: they have settled the lawsuit, and they are now generating cash again – about $11.1 million in free cash in the first 9 months of 2009. Their units, in response, have gone up from about 80 cents at the beginning of the year to $2.50 currently; at 29.3 million units outstanding, that is approximately a market value of $73 million.

The primary hurdle for Menu Foods at this point seems to be the renegotiation of their $75 million debt. If they can achieve this, then unitholders will be sitting pretty and perhaps distributions could continue after they have continued to deleverage their balance sheet. It is interesting to note that a company that was originally on its deathbed is now positioned to survive, in no part due to investors’ risk preferences being expanded in the zero interest rate environment.

A quick look at the top 10 Nasdaq stocks

The following is a very superficial look at the top 10 capitalized companies trading on the Nasdaq (not the NYSE), their market capitalization, and the P/E based on the next fiscal year’s analyst consensus estimates. Also added in are some very quick notes on the respective companies. In order for the index to rise, the top 10 usually must rise as well. I typically do not invest in large capitalization companies because you implicitly are giving up an advantage as a small investor that most large investors do not – the ability to be nimble and build substantial positions in small companies.

Amazon – $58B – P/E 53, pricing in INSANELY high growth, both top line and margins
Amgen – $57B – P/E 11, patent expiration on Epogen coming soon
Apple – $170B – P/E 20, lock on the digital music market, perhaps not the hardware side though, probably under-valued amazingly enough.
Cisco – $139B – P/E 15, essentially a ‘commodity’ network hardware company now
Comcast – $49B – P/E 14, boring cable company
Google – $186B – P/E 22, profiting on any mouse clicks on the internet, decimated traditional media, probably has reached upper end of scale.
Intel – $112B – P/E 14, commodity CPU maker
Microsoft – $264B – P/E 14, commodity OS maker, eroding margins from open source software
Oracle – $113B – P/E 13, commodity DB maker, same thing as Microsoft (they really should merge)
Qualcomm – $75B – P/E 17, basically half the cell calls on the planet (CDMA) make a profit for this company

Why analyst calls are useless

Everybody that is seasoned in the market know that analyst research and projections are designed with the purpose of providing institutional business to the underlying investment brokers. As a result, you very rarely hear analysts giving sell recommendations, unless if the firm in question has already burnt its bridges with the company in question.

At best, this research usually reflects the market consensus, plus or minus a few cents on the earnings per share projection. Analyst research is never the basis for making a trade – instead, it is a quasi-benchmark for how you think the company in question will really perform.

When an analyst is brave enough to see a company that is clearly overvalued and makes a sell recommendation, he is usually looking for an exit out of the firm. For example, a brave analyst called Brian Kennedy made a sell call on a company called CardioNet. He was basically forced out of the company, but his negative projections turned out to be correct.

Note if you cut-and-paste the URL into Google, you can view the entire article.

The moral of the story is that analyst research has a function; but the incentives that analysts have serve the investment banking arms of their companies. Anybody doing very sharp research is most likely trading on that information rather than releasing it to the public, as it is far more profitable to trade with superior information than to try to drum up investment banking business.

Limited Brands Reports Q3 results

I will begin this post by saying I don’t understand the shopping mall experience. Perhaps because of my gender, I just don’t understand why people, usually women, like to “go shopping”.

However, I can understand what goes before my eyes, and that is people shop. I might not understand fashion retail, but I understand the economics of it – something about the marketing works. It gets people to pay more for a product that inherently has very low marginal cost to purchase. The embedded marketing costs, however, are huge.

Earlier this year, I invested in some corporate debt of Limited Brands (NYSE: LTD) – the 2033 series of debentures, which has a coupon of 6.95%. Investors back then assumed that retail was going to get thrown out the window along with the rest of the economy and especially for a discretionary retail shop like Limited Brands (their primary brand name is Victoria’s Secret), droves of people would be not shopping for lingerie. Or will they? According to their last quarterly report, they are on track to bringing in about $500-600M in free cash flow, depending on how the Christmas season works out.

For 35 cents on the dollar, I figured that the debt would be a good buy. It was tough to rationalize how being rewarded 20% interest a year (plus another 4% capital appreciation) under the assumption that Limited Brands would not blow up could lose money. And indeed, it has not lost capital – the same debt is trading for around 71 cents if you shop around carefully. This will still net you 10% a year in coupon payments, and about 1.5% a year capital appreciation compounded over the next 23.8 years.

If you look at their balance sheet, they have about $2.9 billion in debt, covered by $968M in cash, and positive earnings. Although I have no idea whether the retail chain over the next 23.8 years will survive, at least right now it is looking quite good.  The following is the debt maturity schedule from the Q2-2009 SEC filing, which shows they have staggered out their debt financing fairly well:

15. Long-term Debt

The following table provides the Company’s long-term debt balance as of May 2, 2009January 31, 2009 and May 3, 2008:

May 2,
2009
January 31,
2009
May 3,
2008
(in millions)
Term Loan due August 2012. Variable Interest Rate of 5.18% as of May 2, 2009 $ 750 $ 750 $ 750
$700 million, 6.90% Fixed Interest Rate Notes due July 2017, Less Unamortized Discount 698 698 698
$500 million, 5.25% Fixed Interest Rate Notes due November 2014, Less Unamortized Discount 499 499 499
$350 million, 6.95% Fixed Interest Rate Debentures due March 2033, Less Unamortized Discount 350 350 350
$300 million, 7.60% Fixed Interest Rate Notes due July 2037, Less Unamortized Discount 299 299 299
$300 million, 6.125% Fixed Interest Rate Notes due December 2012, Less Unamortized Discount 299 299 299
Credit Facility due January 2010 15
5.30% Mortgage due August 2010 2 2 2
Total 2,897 2,897 2,912
Current Portion of Long-term Debt (7 )
Total Long-term Debt, Net of Current Portion $ 2,897 $ 2,897 $ 2,905

Another similar corporation that is debt-free is Abercrombie and Fitch (NYSE: ANF), which seems to defy everybody’s expectations during recessions by coming back from the financial netherworld to make insane amounts of money. I can see the appeal of Victoria’s Secret – sex sells – but Abercrombie? When walking into the two stores to do some ‘consumer research’, I just don’t understand what keeps these names afloat in the retail fashion world.

However, I can at least invest and make some cash off of it while the going is good. Will I know when it is time to liquidate? Who knows.